When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic
- PMID: 34903185
- PMCID: PMC8667452
- DOI: 10.1186/s12887-021-02911-w
When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic
Abstract
Background: Infectious diseases account for the third most common cause of neonatal deaths. Globally, antibiotic resistance (ABR) has been increasingly challenging neonatal sepsis treatment, with 26 to 84% of gram-negative bacteria resistant to third-generation cephalosporins. In sub-Saharan Africa, limited evidence is available regarding the neonatal microbiology and ABR. To our knowledge, no studies have assessed neonatal bacterial infections and ABR in Central-African Republic (CAR). Therefore, this study aimed to describe the pathogens isolated and their specific ABR among patients with suspected antibiotic-resistant neonatal infection admitted in a CAR neonatal unit.
Methods: This retrospective cohort study included neonates admitted in the neonatal unit in Bangui, CAR, from December 2018 to March 2020, with suspected antibiotic-resistant neonatal infection and subsequent blood culture. We described the frequency of pathogens isolated from blood cultures, their ABR prevalence, and factors associated with fatal outcome.
Results: Blood cultures were positive in 33 (26.6%) of 124 patients tested (17.9% for early-onset and 46.3% for late-onset infection; p = 0.002). Gram-negative bacteria were isolated in 87.9% of positive samples; with most frequently isolated bacteria being Klebsiella pneumoniae (39.4%), Escherichia coli (21.2%) and Klebsiella oxytoca (18.2%). All tested bacteria were resistant to ampicillin. Resistance to third-generation cephalosporins was observed in 100% of tested Klebsiella pneumoniae, 83.3% of isolated Klebsiella oxytoca and 50.0% of tested Escherichia coli. None of the tested bacteria were resistant to carbapenems. Approximately 85.7 and 77.8% of gram-negative tested bacteria were resistant to first-line (ampicillin-gentamicin) and second-line (third-generation cephalosporins) treatments, respectively. In hospital mortality, adjusted for blood culture result, presence of asphyxia, birth weight and sex was higher among neonates with positive blood culture (adjusted relative risk [aRR] = 2.32; 95% confidence interval [CI] = 1.17-4.60), male sex (aRR = 2.07; 95% CI = 1.01-4.26), asphyxia (aRR = 2.42; 95% CI = 1.07-5.47) and very low birth weight (1000-1499 g) (aRR = 2.74; 95% CI = 1.3-5.79).
Conclusion: Overall, 77.8% of confirmed gram-negative neonatal infections could no longer effectively be treated without broad-spectrum antibiotics that are not routinely used in sub-Saharan Africa referral hospitals. Carbapenems should be considered an option in hospitals with surveillance and antibiotic stewardship.
Keywords: Antibiotic resistance; Blood culture; Central-African Republic; Escherichia coli; Gram-negative bacteria; Klebsiella; Neonatal infection; Neonatal intensive care unit; Neonatal sepsis; Sub-Saharan Africa..
© 2021. The Author(s).
Conflict of interest statement
The authors declare they have no competing interests.
Similar articles
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
-
Blood culture result profile and antimicrobial resistance pattern: a report from neonatal intensive care unit (NICU), Asella teaching and referral hospital, Asella, south East Ethiopia.Antimicrob Resist Infect Control. 2019 Feb 20;8:42. doi: 10.1186/s13756-019-0486-6. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 30828446 Free PMC article.
-
Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study.Lancet Glob Health. 2016 Oct;4(10):e752-60. doi: 10.1016/S2214-109X(16)30148-6. Lancet Glob Health. 2016. PMID: 27633433
-
Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia.Pediatr Infect Dis J. 2016 Jul;35(7):e191-8. doi: 10.1097/INF.0000000000001154. Pediatr Infect Dis J. 2016. PMID: 27031259
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
Cited by
-
Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A scoping review.Wellcome Open Res. 2024 Nov 22;9:692. doi: 10.12688/wellcomeopenres.23133.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 39931110 Free PMC article.
-
Prevalence of Antimicrobial Resistance in Klebsiella pneumoniae, Enterobacter cloacae, and Escherichia coli Isolates among Stillbirths and Deceased Under-Five Children in Sierra Leone: Data from the Child Health and Mortality Prevention Surveillance Sites from 2019 to 2022.Microorganisms. 2024 Aug 13;12(8):1657. doi: 10.3390/microorganisms12081657. Microorganisms. 2024. PMID: 39203499 Free PMC article.
-
Antibiotic susceptibility pattern among children admitted to a hospital in Nigeria: A retrospective study.Afr J Lab Med. 2024 Aug 20;13(1):2362. doi: 10.4102/ajlm.v13i1.2362. eCollection 2024. Afr J Lab Med. 2024. PMID: 39228901 Free PMC article.
-
Neonatal Paenibacilliosis: Paenibacillus Infection as a Novel Cause of Sepsis in Term Neonates With High Risk of Sequelae in Uganda.Clin Infect Dis. 2023 Sep 11;77(5):768-775. doi: 10.1093/cid/ciad337. Clin Infect Dis. 2023. PMID: 37279589 Free PMC article.
-
Antimicrobial resistance in Enterobacterales infections among children in sub-Saharan Africa: a systematic review and meta-analysis.EClinicalMedicine. 2024 Mar 8;70:102512. doi: 10.1016/j.eclinm.2024.102512. eCollection 2024 Apr. EClinicalMedicine. 2024. PMID: 38495519 Free PMC article.
References
-
- Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, Adetokunboh O, Afshin A, Agrawal A, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151–1210. doi: 10.1016/S0140-6736(17)32152-9. - DOI - PMC - PubMed
-
- UN Inter-agency Group for Child Mortality Estimation: Level & trends in child mortality report 2019. In.; 2019.
-
- Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200–211. doi: 10.1016/S0140-6736(19)32989-7. - DOI - PMC - PubMed
-
- Li G, Bielicki JA, Ahmed A, Islam MS, Berezin EN, Gallacci CB, Guinsburg R, da Silva Figueiredo CE, Santarone Vieira R, Silva AR, et al. Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network. Arch Dis Child. 2020;105(1):26–31. doi: 10.1136/archdischild-2019-316816. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical